SCOTTSDALE, Ariz., April 15 /PRNewswire-FirstCall/ -- This press release was issued today by Motion DNA Corporation:
"We continue to be extremely optimistic about Motion DNA Corporation's long-term potential and expect that the new operational steps the company has outlined for the future will improve the company's ability to more fully and rapidly penetrate its target markets," stated Mr. Zig Ziegler, President and Founder of Motion DNA.
Within the last 12 months, Motion DNA has developed and released two new products, BioCap and BioTrainer. Motion DNA is expected to announce the completion of a new product aimed at the consumer market and target increased sales of its existing products to physical therapists, chiropractors and other medical professionals.
For 2005, the product development team, led by Jason Bodine, Senior Vice President of the company, has also worked behind closed doors on an aspect of its technology that has never been developed before in motion capture. Motion DNA has retained the law firm of Greenburg-Traurig as corporate counsel to handle all legal issues including the filing of patents for the new product. Once the patent applications have been submitted and the application pending, Motion DNA will start marketing of this revolutionary new product.
"This is a great time for Motion DNA," said Zig Ziegler, President of Motion DNA. "Interest in our products and services is at an all-time high as athletes and strength coaches are looking for new ways to gain an edge."
Motion DNA has updated its projections for the final three quarters of 2005. Strengthened by anticipated deals with professional sports leagues and the addition of several new retail products, the company expects revenue in last nine calendar months 2005 to surpass $2,500,000, an expected 250% increase over the same period in 2004. Full details of those projections are expected to be available by the close of business today via the pinksheets.com news service or directly on the Motion DNA web site at http://www.motiondnacorp.com/.
"Again, as stated in yesterday's press release, the company plans to keep communications open regularly to help increase investor awareness of its on-going day-to-day operations," said Ziegler. "An internal shareholder awareness program is being launched to coincide with today's news. The internal campaign is expected to include weekly company news, a monthly shareholder newsletter, and an on-line or telephone conference with the an officer of the company every quarter."
Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications that may arise could prevent the prompt implementation of any strategically significant plan(s) outlined above. The company cautions that these forward-looking statements are further qualified by other factors. The company undertakes no obligation to publicly update or revise any statements in this release, whether as a result of new information, future events or otherwise.
For more information on Motion DNA Contact: Investor Relations Motion DNA Corporation 15023 N. 73rd Street Scottsdale, Arizona 85260 1.877.425.7734 toll free 480.425.7734 phone 480.991.7736 fax
Motion DNA CorporationCONTACT: Investors, Motion DNA Corporation, +1-877-425-7734 (toll free),or +1-480-425-7734, or fax, +1-480-991-7736
Web site: http://www.motiondnacorp.com/